Related Experiment Videos
Cerebral transplantation for Parkinson's disease: current progress and future prospects
1Department of Neurology, Mayo Clinic Rochester, MN 55905.
Mayo Clinic Proceedings
|June 1, 1993
Summary
Cerebral transplantation shows promise for Parkinson's disease, with fetal cell grafts offering improvements. However, graft survival and consistent replication remain challenges, necessitating further research for routine clinical use.
Area of Science:
- Neuroscience
- Neurosurgery
- Regenerative Medicine
Background:
- Cerebral transplantation is explored as a Parkinson's disease (PD) treatment.
- Early trials used adrenal-to-brain grafts with inconsistent results.
- Fetal dopaminergic mesencephalon grafts have shown recent promise.
Purpose of the Study:
- To review the status of cerebral transplantation for Parkinson's disease.
- To evaluate the efficacy and challenges of current transplantation techniques.
- To discuss future directions in PD cell-based therapies.
Main Methods:
- Review of animal models and early human trials of cerebral transplantation for PD.
- Analysis of outcomes from adrenal medullary and fetal mesencephalon grafts.
- Consideration of graft survival, dopamine secretion, and neurotrophic factors.
Main Results:
- Adrenal grafts had inconsistent success; graft survival was a key issue.
- Fetal dopaminergic grafts provided substantial improvement in some PD patients.
- Most patients receiving fetal grafts still required levodopa therapy, indicating incomplete reversal.
Conclusions:
- Fetal mesencephalon transplantation is a promising PD treatment but requires refinement.
- Graft survival and technical issues must be addressed before routine use.
- Future strategies may involve genetically engineered cells or viral vector modification.